Skip to content

CMND

Clearmind Medicine, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$6.00
−4.15%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue54.3K49.4K51.1K57.4K119.6K
Gross Profit(54.3K)(49.4K)(51.1K)(57.4K)(119.6K)
Operating Expenses
R&D Expense2.3M2.0M1.4M1.5M4.4M
SG&A Expense6.5M3.6M4.3M4.7M4.5M
General & Admin Expense—————
Selling & Marketing Expense—————
Other Expenses—————
Total Operating Expenses8.8M5.6M5.7M6.2M8.9M
Cost and Expenses8.9M5.7M5.7M6.3M9.0M
Operating Income (EBIT)(8.9M)(5.7M)(5.7M)(6.3M)(9.0M)
Non-Operating
Interest Income238.3K132.9K271.2K59.1K—
Interest Expense13.6K19.5K36.2K—20.8K
Net Interest Income224.6K113.4K235.1K59.1K(20.8K)
Other Non-Op Income/Expense1.4M1.9M868.2K(2.3M)(883.5K)
Non-Operating Income (excl Interest)(584.0K)(1.9M)(904.4K)2.3M862.8K
EBT (Pre-Tax Income)(7.5M)(3.8M)(4.9M)(8.6M)(9.9M)
Income Tax Expense12.7K70.4K378.0K17.3K43.0K
Bottom Line
Net Income(7.5M)(3.9M)(5.3M)(8.6M)(9.9M)
Earnings from Cont. Ops(7.5M)(3.9M)(5.3M)(8.6M)(9.9M)
Earnings from Discont. Ops—————
Bottom Line Net Income(7.5M)(3.9M)(5.3M)(8.6M)(9.9M)
Per Share
Basic EPS($89.20)($24.24)($54.24)($1,360.56)($7,331.52)
Diluted EPS($89.20)($24.24)($54.24)($1,360.56)($7,331.52)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding1977721588669687963281354
Diluted Shares Outstanding1977721588669687963281354
Profitability Metrics
EBITDA(8.2M)(3.7M)(4.8M)(8.5M)(9.8M)
D&A54.3K49.4K51.1K57.5K113.0K
EBIT(8.3M)(3.8M)(4.8M)(8.6M)(9.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jul 1, 2026